Integration of CMR Scar Imaging and Electroanatomic Mapping The Future of VT Ablation?⁎⁎Editorials published in JACC: Cardiovascular Imaging reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Imaging or the American College of Cardiology. by Bilchick, Kenneth C.
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 5 , N O . 2 , 2 0 1 2
© 2 0 1 2 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c m g . 2 0 1 1 . 0 9 . 0 2 1E D I T O R I A L C O M M E N T
Integration of CMR Scar Imaging and
Electroanatomic Mapping
The Future of VT Ablation?*
Kenneth C. Bilchick, MD, MS
Charlottesville, Virginiam
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UIn this issue of iJACC, Gupta et al. (1) present their
single-center experience with intraprocedural
3-dimensional registration of cardiac magnetic res-
onance (CMR) scar mapping with voltage maps
created at the time of ablation of ventricular tachy-
cardia (VT) or premature ventricular contractions
(PVCs) in 23 post-infarction patients. The meth-
odology involves using 3 standard landmarks—the
aortic root, mitral annulus plane, and left ventricular
apex—to integrate voltage and scar maps, which
allows more focused mapping of VT in areas with
scar. Although there is previous experience with
post hoc integration of CMR scar and voltage maps
(2–5), the novel feature of this contribution is the
See page 207
use of this methodology to guide the VT ablation
procedure. At the same time, the study raises several
questions. First, is this methodology likely to im-
prove the efficiency and success rates of VT ablation
in the future? Second, does this methodology have
the potential to be applied broadly to most patients
undergoing VT ablation? Third, are there other
imaging techniques likely to be more effective or
more broadly applicable for patients undergoing VT
ablation?
The rationale for the use of CMR for VT
ablation in post-infarction patients is based on the
relationship between scar and ventricular arrhyth-
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.
From the Department of Medicine, University of Virginia Health System,
Charlottesville, Virginia. Dr. Bilchick is supported by NIH grant K23G
HL094761. Dr. Bilchick has reported that he has no relationships relevant
to the contents of this paper to disclose.ia. VT often occurs in patients with healed
yocardial infarctions because slow conduction
hrough surviving myocytes in and around the
nfarction facilitates reentry, the usual mechanism
f sustained post-infarction VT. The exit site for
hese reentrant VTs is usually located along the
order zone of the scar (6). Nonsustained VT and
VCs also occur and may come from the infarct
one, although multiple mechanisms are possible
or isolated PVCs, including enhanced automatic-
ty, triggered activity, and localized reentry.
The distribution of myocardial scar is of interest
uring the ablation procedure because post-
nfarction VT usually arises from myocardial scar.
nfarction appears bright on CMR late gadolini-
m–enhanced imaging, giving a clear delineation of
he infarct size, borders, and transmurality. Al-
hough CMR assesses the full extent of scar, endo-
ardial electroanatomic mapping (EAM) may be
ess sensitive to scar involving the midwall or
ubepicardium only. For example, a significant dif-
erence in bipolar voltage between endocardial ver-
us intramural and epicardial scar (0.94  1.07 mV
s. 1.52  1.41 mV; p  0.01) has been described
2). Fortunately, because post-infarction scars usu-
lly involve the subendocardium, endocardial EAM
hould effectively identify areas with myocardial
nfarction. In fact, pathological studies have shown
hat infarct size from bipolar EAM voltages of
1.0 mV highly correlate with infarct size on the
asis of pathology (r  0.98; p  0.0001) (7).
In this way, the rationale for the use of CMR in
he context of EAM for VT ablation is that more
ccurate identification of scar and thus critical
blation sites can be achieved more efficiently.
nfortunately, no conclusions can be made from
upta et al. (1) with respect to relative efficacy due
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212to the absence of a control group; however, the
study did find that 92% of low-voltage points were
within 5 mm of scar. Also, all critical sites identified
during ablation (defined as sites resulting in elimi-
nation of PVCs or termination of VT) projected
onto scar, which is consistent with the findings of a
previous series of patients evaluated by this group
(5). From a clinical standpoint, the patients did very
well after the procedure, with an overall reduction
in PVC burden of 96% and no recurrent VT in 9 of
10 patients. Whether similar efficacy rates would
have been achieved using a standard approach is
unknown on the basis of the results of this study.
The next question is whether the methodology
has the potential to have a broad impact on the care
of post-infarction patients with VT and PVCs. The
answer requires consideration of the role of VT
ablation in post-infarction patients and other char-
acteristics of patients undergoing the procedure. In
addition to catheter ablation, strategies to treat VT
in post-infarction patients include implantable
cardioverter-defibrillators (ICDs) (8) and pharma-
cologic therapy, with the specific strategy tailored to
the individual patient. In patients with ICDs,
catheter ablation is typically performed for sus-
tained ventricular arrhythmia, often after drug fail-
ure. Alternatively, prophylactic substrate-based ab-
lation may be performed in post-infarction patients
before ICD implantation (9). PVCs may be tar-
geted for ablation in patients who already have
ICDs implanted for primary prevention of sudden
cardiac death or in others with less severe left
ventricular systolic dysfunction.
The presence of an ICD is an impediment at this
time to the routine use of CMR in these patients
(10). Even if performed as part of a research
protocol (11), artifact from the ICD may obscure
the characterization of myocardial scar, particularly
in patients with anterior infarcts or not much
separation between the ICD and cardiac silhouette
on chest radiography. For this reason, patients who
have not already received an ICD for primary
prevention of sudden cardiac death or those under-207–10. and infarct transmthe best candidates for intraprocedural CMR scar
registration. The methodology could also be applied
to prophylactic substrate-based ablation in post-
infarction patients before ICD implantation. Of
note, the utility of CMR for endocardial ablation in
nonischemic cardiomyopathy may be diminished if
scar has a predominant intramural or epicardial
distribution.
The last question is whether CMR is indeed the
best adjunctive imaging modality to identify scar in
these patients. Particularly in patients with ICDs,
cardiac computed tomography with or without
positron emission tomography is another important
methodology to identify myocardial scar in 3 di-
mensions (12), although the quality of scar imaging
obtained in this way does not equal that of CMR.
In addition, intracardiac echocardiography has been
used to identify scar during VT ablation (13). In
this study of 18 patients, thinned, akinetic areas by
intracardiac echocardiography had an accuracy of 87%
in identifying scar on the basis of voltage criteria in the
post-infarction patients. Although echocardiography
is not as specific for scar as CMR, it would have
broader applicability in patients with ICDs and offers
accurate real-time left ventricular contours.
In conclusion, Gupta et al. (1) present a descriptive
account of real-time registration of 3-dimensional scar
maps from CMR images with the voltage map
obtained using EAM during VT ablation. Their
results extend their previously published association
between critical ablation sites and areas of scar on
the basis of CMR to the real-time setting, indicat-
ing that this technique may facilitate more efficient
mapping of scar-associated VT and isolated PVCs
in selected patients. There was no control group,
and application may be limited in post-infarction
patients with ICDs, but the results are promising
and justify further clinical study.
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